Camp4 Therapeutics Corporation
CAMP
$1.55
-$0.04-2.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.24% | 6.37% | 1.52% | -7.22% | -1.00% |
| Total Depreciation and Amortization | 2.14% | 0.72% | 0.00% | -1.42% | -2.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.22% | 13.40% | -38.09% | 66.21% | -3.58% |
| Change in Net Operating Assets | 111.50% | -1,352.86% | -77.36% | 151.94% | -511.62% |
| Cash from Operations | 27.60% | -26.56% | -16.46% | 27.87% | -20.60% |
| Capital Expenditure | 100.00% | -6.08% | -- | 100.00% | -986.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -6.08% | -- | 100.00% | -986.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 147.68% | 28.44% | -2.93% | -0.49% | 0.00% |
| Issuance of Common Stock | -- | -- | 246,458.06% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1,390.57% | 65.13% | -- |
| Cash from Financing | 147.68% | -100.21% | 19,027.98% | 52.46% | -301.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.21% | -123.92% | 710.29% | 30.07% | -26.88% |